Publications 2025

Al Haidari G, Solbakken AM, Åsli LM, Skovlund E, Undseth C, Guren MG (2025)
Treatment and outcomes for locally recurrent rectal cancer in Norway
Acta Oncol, 64, 784-792
DOI 10.2340/1651-226X.2025.42991, PubMed 40500960

Ascierto PA, Tang H, Dolfi S, Nyakas M, Marie Svane I, Muñoz-Couselo E, Grob JJ, Gomez-Roca CA, Chiarion-Sileni V, Peltola K, Larkin J, Melero I, Callahan M, Dummer R, Djidel P, Warad D, Reusser-Wolf D, Lipson EJ, Garnett-Benson C (2025)
Effect of prior and first-line immunotherapy on baseline immune biomarkers and modulation of the tumor microenvironment in response to nivolumab and relatlimab combination therapy in patients with melanoma from RELATIVITY-020
J Immunother Cancer, 13 (2)
DOI 10.1136/jitc-2024-009773, PubMed 40010775

Bregni G, Adams R, Bale R, Bali MA, Bargellini I, Blomqvist L, Brown G, Cremolini C, Demetter P, Denecke T, Dohan A, Dopazo C, Elez E, Evrard S, Feakins R, Guckenberger M, Guren MG, Hawkins M, Hoorens A, Huguet E, Intven M, Koessler T, Kunz WG, Lordick F, Lucidi V et al. (2025)
EORTC consensus recommendations on the optimal management of colorectal cancer liver metastases
Cancer Treat Rev, 136, 102926
DOI 10.1016/j.ctrv.2025.102926, PubMed 40179590